|
|
|
 |
|
|
 |
 |
Teva Pharmaceutical Industries Limited
Company
Snapshot Purchase a Full Report on this Company
Business Description:
Teva Pharmaceutical Industries Limited. The Group's principal activities are to involve in the development, manufacturing, marketing and distribution of Pharmaceuticals and Active Pharmaceutical Ingredients. The Group operates under two segments: Pharmaceutical and API. Under Pharmaceutical, the Group involves in the development, production, marketing and distribution of drugs in various dosages and forms, in most areas of medicinal treatment and disposable hospital supplies. Under API, the Group involves in the development, production, marketing and distribution of API for the pharmaceutical industry. The Group manufactures solid dosage forms, injectables, liquids, semi-solids and inhalers. The products of the Group include Copaxone and Azilect. The Group operates with 34 dosage pharmaceutical plants in North America, Latin America, Europe, Israel and China. The majority of the Group's sales are in North America and Western Europe. It acquired Barr in 2008.
|
|
| |
Wright Quality Rating:
NAB1 Rating Explanations |
| |
|
| |
|
| |
|
|
|
|
|
|
| |
| |
Stock Data: |
Recent Stock Performance: |
|
| |
Current Price (2/5/2010):
56.76
(Figures in
U.S. Dollars) |
|
1 Week |
0.1% |
|
13 Weeks |
-4.3% |
|
|
|
|
|
|
|
|
|
4 Weeks |
9.1% |
|
52 Weeks |
35.1% |
|
|
|
| |
| |
Teva Pharmaceutical Industries Limited
Key Data: |
|
|
|
| |
Ticker: |
TEVA |
Country: |
ISRAEL |
| |
|
| |
Exchanges: |
NAS |
Major Industry: |
Drugs, Cosmetics & Health Care |
| |
|
| |
|
|
Sub Industry: |
Ethical Drug Manufacturers |
| |
|
| |
2008
Sales |
11,084,997,210
(Year Ending Jan 2009). |
Employees: |
38,307 |
| |
|
| |
Currency: |
U.S. Dollars |
Market Cap: |
52,156,253,160 |
| |
|
| |
Fiscal Yr Ends: |
December |
Shares Outstanding: |
918,891,000 |
| |
|
| |
Share Type: |
Ordinary |
Closely Held Shares: |
41,235,075 |
|
| |
|
| |
| |
|
|
|
|
| |
Purchase a Full Subscription to All Reports From CorporateInformation: |
|
|
|
| |
The following reports, available for Teva Pharmaceutical Industries Limited, are typical of the content provided on all companies
covered in CorporateInformation.com
Basic Reports
Teva Pharmaceutical Industries Limited company Profile (Business Description, Price/Earnings, Price/Sales,
Price/Book, Dividend Yield, Company Officers, Contact Information), Competitor Analysis and up to ten-year history of Sales, Earnings per Share,
Dividends per Share, Security Price and Key Ratios. View Samples
Financial Statement Reports
Research reports that analyze Teva Pharmaceutical Industries Limited Income Statement and Balance Sheet along with
the Sources of Capital for a five-year period. View Samples
Financial Ratio Reports
Analyses reports that highlight Teva Pharmaceutical Industries Limited
Accounting Ratios, Asset Utilization, Fixed Charges Coverage, Liquidity, Leverage, Profitability,
Employee Efficiency and Per-Share Data over a five-year period. View Samples
Wright Quality Analyses Reports
Wright’s proprietary rating of corporate quality. The reports include a detailed
analysis of Teva Pharmaceutical Industries Limited Equity, Liquidity, Financial Strength,
Profitability and Corporate Growth. View Samples |
| |
|
|
| |
|
|
|
 |
|
|
|
|
|
|
|
CorporateInformation® website and selected data Copyright © 2000 -
by The Winthrop Corporation. All Rights Reserved. Except for quotations by established
news media, no pages on this site may be reproduced, stored in a retrieval system,
or transmitted for commercial purposes, in any form or by any means, electronic,
mechanical, photocopying, recording, or otherwise without prior written permission.
Information is believed reliable, but accuracy, completeness and opinions are not
guaranteed.
|
|
|
|